Medytox, Stock Price +3.74% at This Time... Foreigners Net Sell 15,847 Shares in Last 5 Days

As of 11:30 AM on the 23rd, Medytox is trading at 205,000 KRW, up 3.74% from the previous day. The trading volume is 882,936 shares, which is 333.03% of the previous day's volume. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

On February 22, Hana Financial Investment researcher Sun Min-jung announced, "As of February 19, US time, Medytox, Allergan, and Evolus have reached a sudden settlement regarding the ITC lawsuit and intellectual property lawsuit that resulted in a 21-month sales ban of Nabota in the US. As a result, Evolus can now sell Nabota in the US, and the lawsuit filed by Medytox against Evolus in California will be withdrawn. Contracts are segmented between the US and the Rest of the World (ROW). With this settlement with Evolus, Medytox is expected to gain significant practical benefits." She set Medytox's target price at 430,000 KRW.

Over the past five days, individual investors have net bought 925 shares of Medytox, while foreign investors and institutions have net sold 15,847 shares and net bought 2,156 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.